E. Leroy, M. Trojanowska, and E. Smith, Cytokines and human fibrosis, Eur Cytokine Netw, vol.1, pp.215-219, 1990.

M. Schiller, D. Javelaud, and A. Mauviel, TGF-??-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing, Journal of Dermatological Science, vol.35, issue.2, pp.83-92, 2004.
DOI : 10.1016/j.jdermsci.2003.12.006

URL : https://hal.archives-ouvertes.fr/inserm-00147401

G. Grotendorst, Connective tissue growth factor: a mediator of TGF-?? action on fibroblasts, Cytokine & Growth Factor Reviews, vol.8, issue.3, pp.171-179, 1997.
DOI : 10.1016/S1359-6101(97)00010-5

A. Leask, C. Denton, and D. Abraham, Insights Into the Molecular Mechanism of Chronic Fibrosis: The Role of Connective Tissue Growth Factor in Scleroderma, Journal of Investigative Dermatology, vol.122, issue.1, pp.1-6, 2004.
DOI : 10.1046/j.0022-202X.2003.22133.x

X. Feng and R. Derynck, SPECIFICITY AND VERSATILITY IN TGF-?? SIGNALING THROUGH SMADS, Annual Review of Cell and Developmental Biology, vol.21, issue.1, pp.659-693, 2005.
DOI : 10.1146/annurev.cellbio.21.022404.142018

A. Roberts, Molecular and Cell Biology of TGF-??, Mineral and Electrolyte Metabolism, vol.24, issue.2-3, pp.111-119, 1998.
DOI : 10.1159/000057358

J. Annes, J. Munger, and D. Rifkin, Making sense of latent TGFbeta activation, Journal of Cell Science, vol.116, issue.2, pp.217-224, 2003.
DOI : 10.1242/jcs.00229

P. Dijke and C. Hill, New insights into TGF-?????Smad signalling, Trends in Biochemical Sciences, vol.29, issue.5, pp.265-273, 2004.
DOI : 10.1016/j.tibs.2004.03.008

L. Gilboa, R. Wells, H. Lodish, and Y. Henis, Oligomeric Structure of Type I and Type II Transforming Growth Factor ?? Receptors: Homodimers Form in the ER and Persist at the Plasma Membrane, The Journal of Cell Biology, vol.15, issue.4, pp.767-777, 1998.
DOI : 10.1038/383168a0

T. Tsukazaki, T. Chiang, A. Davison, L. Attisano, and J. Wrana, SARA, a FYVE Domain Protein that Recruits Smad2 to the TGF?? Receptor, Cell, vol.95, issue.6, pp.779-791, 1998.
DOI : 10.1016/S0092-8674(00)81701-8

Y. Shi, A. Hata, R. Lo, J. Massague, and N. Pavletich, A structural basis for mutational inactivation of the tumour suppressor Smad4, Nature, vol.388, pp.87-93, 1997.

Y. Shi and J. Massague, Mechanisms of TGF-?? Signaling from Cell Membrane to the Nucleus, Cell, vol.113, issue.6, pp.685-700, 2003.
DOI : 10.1016/S0092-8674(03)00432-X

P. Bornstein and H. Sage, Regulation of Collagen Gene Expression, Prog Nucleic Acid Res Mol Biol, vol.37, pp.67-106, 1989.
DOI : 10.1016/S0079-6603(08)60695-9

A. Ghosh, Factors involved in the regulation of type I collagen gene expression: implication in fibrosis, Exp Biol Med (Maywood), vol.227, pp.301-314, 2002.

M. Trojanowska, E. Leroy, B. Eckes, and T. Krieg, Pathogenesis of fibrosis: type 1 collagen and the skin, Journal of Molecular Medicine, vol.76, issue.3-4, pp.266-274, 1998.
DOI : 10.1007/s001090050216

S. Jimenez, J. Varga, A. Olsen, L. Li, A. Diaz et al., Functional analysis of human alpha 1(I) procollagen gene promoter. Differential activity in collagen-producing and -nonproducing cells and response to transforming growth factor beta 1, J Biol Chem, vol.269, pp.12684-12691, 1994.

Y. Inagaki, S. Truter, and F. Ramirez, Transforming growth factorbeta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site, J Biol Chem, vol.269, pp.14828-14834, 1994.

Y. Inagaki, S. Truter, S. Tanaka, D. Liberto, M. Ramirez et al., Overlapping pathways mediate the opposing actions of tumor necrosis factor-alpha and transforming growth factor-beta on alpha 2(I) collagen gene transcription, J Biol Chem, vol.270, pp.3353-3358, 1995.

K. Chung, A. Agarwal, J. Uitto, and A. Mauviel, An AP-1 Binding Sequence Is Essential for Regulation of the Human 2(I) Collagen (COL1A2) Promoter Activity by Transforming Growth Factor-, Journal of Biological Chemistry, vol.271, issue.6, pp.3272-3278, 1996.
DOI : 10.1074/jbc.271.6.3272

F. Verrecchia, J. Rossert, and A. Mauviel, Blocking Sp1 Transcription Factor Broadly Inhibits Extracellular Matrix Gene Expression In Vitro and In Vivo: Implications for the Treatment of Tissue Fibrosis, Journal of Investigative Dermatology, vol.116, issue.5, pp.755-763, 2001.
DOI : 10.1046/j.1523-1747.2001.01326.x

S. Chen, W. Yuan, Y. Mori, A. Levenson, M. Trojanowska et al., Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-??: Involvement of Smad 3, Journal of Investigative Dermatology, vol.112, issue.1, pp.49-57, 1999.
DOI : 10.1046/j.1523-1747.1999.00477.x

A. Poncelet and H. Schnaper, Sp1 and Smad Proteins Cooperate to Mediate Transforming Growth Factor-??1-induced ??2(I) Collagen Expression in Human Glomerular Mesangial Cells, Journal of Biological Chemistry, vol.276, issue.10, pp.6983-6992, 2001.
DOI : 10.1074/jbc.M006442200

S. Dennler, V. Pendaries, C. Tacheau, M. Costas, A. Mauviel et al., The steroid receptor co-activator-1 (SRC-1) potentiates TGF-??/Smad signaling: role of p300/CBP, Oncogene, vol.24, issue.11, pp.1936-1945, 2005.
DOI : 10.1038/sj.onc.1208343

L. Vindevoghel, R. Lechleider, A. Kon, M. De-caestecker, J. Uitto et al., SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor ??, Proceedings of the National Academy of Sciences, vol.95, issue.25, pp.14769-14774, 1998.
DOI : 10.1073/pnas.95.25.14769

S. Dennler, S. Itoh, D. Vivien, P. Ten-dijke, S. Huet et al., Direct binding of Smad3 and Smad4 to critical TGFbeta -inducible elements in the promoter of human plasminogen activator inhibitor-type 1gene, The EMBO Journal, vol.17, issue.11, pp.3091-3100, 1998.
DOI : 10.1093/emboj/17.11.3091

S. Chen, W. Yuan, S. Lo, M. Trojanowska, and J. Varga, Interaction of Smad3 with a proximal smad-binding element of the human ?2(I) procollagen gene promoter required for transcriptional activation by TGF-?, Journal of Cellular Physiology, vol.2, issue.3, pp.381-392, 2000.
DOI : 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O

F. Verrecchia, M. Chu, and A. Mauviel, Identification of Novel TGF-??/Smad Gene Targets in Dermal Fibroblasts using a Combined cDNA Microarray/Promoter Transactivation Approach, Journal of Biological Chemistry, vol.276, issue.20, pp.17058-17062, 2001.
DOI : 10.1074/jbc.M100754200

W. Yuan and J. Varga, Transforming Growth Factor-?? Repression of Matrix Metalloproteinase-1 in Dermal Fibroblasts Involves Smad3, Journal of Biological Chemistry, vol.276, issue.42, pp.38502-38510, 2001.
DOI : 10.1074/jbc.M107081200

G. Chin, W. Liu, Z. Peled, T. Lee, D. Steinbrech et al., Differential Expression of Transforming Growth Factor-?? Receptors I and II and Activation of Smad 3 in Keloid Fibroblasts, Plastic and Reconstructive Surgery, vol.108, issue.2, pp.423-429, 2001.
DOI : 10.1097/00006534-200108000-00022

T. Phan, I. Lim, O. Aalami, F. Lorget, A. Khoo et al., Smad3 signalling plays an important role in keloid pathogenesis via epithelial???mesenchymal interactions, The Journal of Pathology, vol.65, issue.2, pp.232-242, 2005.
DOI : 10.1002/path.1826

M. Martin, J. Lefaix, and S. Delanian, TGF-??1 and radiation fibrosis: a master switch and a specific therapeutic target?, International Journal of Radiation Oncology*Biology*Physics, vol.47, issue.2, pp.277-290, 2000.
DOI : 10.1016/S0360-3016(00)00435-1

J. Archambeau, R. Pezner, and T. Wasserman, Pathophysiology of irradiated skin and breast, International Journal of Radiation Oncology*Biology*Physics, vol.31, issue.5, pp.1171-1185, 1995.
DOI : 10.1016/0360-3016(94)00423-I

R. Peter, O. Braun-falco, A. Birioukov, N. Hacker, M. Kerscher et al., Chronic cutaneous damage after accidental exposure to ionizing radiation: The Chernobyl experience, Journal of the American Academy of Dermatology, vol.30, issue.5, pp.719-723, 1994.
DOI : 10.1016/S0190-9622(08)81501-0

P. Rubin, C. Johnston, J. Williams, S. Mcdonald, and J. Finkelstein, A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis, International Journal of Radiation Oncology*Biology*Physics, vol.33, issue.1, pp.99-109, 1995.
DOI : 10.1016/0360-3016(95)00095-G

F. Verrecchia, A. Mauviel, and D. Farge, Transforming growth factor-?? signaling through the Smad proteins: Role in systemic sclerosis, Autoimmunity Reviews, vol.5, issue.8, pp.563-569, 2006.
DOI : 10.1016/j.autrev.2006.06.001

URL : https://hal.archives-ouvertes.fr/inserm-00166114

Y. Mori, S. Chen, and J. Varga, Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts, Arthritis & Rheumatism, vol.42, issue.7, pp.1964-1978, 2003.
DOI : 10.1002/art.11157

C. Dong, S. Zhu, T. Wang, W. Yoon, Z. Li et al., Deficient Smad7 expression: A putative molecular defect in scleroderma, Proceedings of the National Academy of Sciences, vol.99, issue.6, pp.3908-3913, 2002.
DOI : 10.1073/pnas.062010399

U. Bartram and C. Speer, The Role of Transforming Growth Factor ?? in Lung Development and Disease, Chest, vol.125, issue.2, pp.754-765, 2004.
DOI : 10.1378/chest.125.2.754

A. Limper, T. Broekelmann, T. Colby, G. Malizia, J. Mcdonald et al., Analysis of local mRNA expression for extracellular matrix proteins and growth factors using in situ hybridization in fibroproliferative lung disorders Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis, Chest Proc Natl Acad Sci, vol.99, issue.88, pp.55-56, 1991.

A. Ludwicka, T. Ohba, M. Trojanowska, A. Yamakage, C. Strange et al., Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma, J Rheumatol, vol.22, pp.1876-1883, 1995.

C. Wojnarowski, T. Frischer, E. Hofbauer, C. Grabner, W. Mosgoeller et al., Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation, European Respiratory Journal, vol.14, issue.5, pp.1136-1144, 1999.
DOI : 10.1183/09031936.99.14511369

G. Euler-taimor and J. Heger, The complex pattern of SMAD signaling in the cardiovascular system???, Cardiovascular Research, vol.69, issue.1, pp.15-25, 2006.
DOI : 10.1016/j.cardiores.2005.07.007

C. Runyan, H. Schnaper, and A. Poncelet, -induced collagen I expression in human mesangial cells, American Journal of Physiology - Renal Physiology, vol.285, issue.3, pp.413-422, 2003.
DOI : 10.1152/ajprenal.00082.2003

E. Bottinger and M. Bitzer, TGF-?? Signaling in Renal Disease, Journal of the American Society of Nephrology, vol.13, issue.10, pp.2600-2610, 2002.
DOI : 10.1097/01.ASN.0000033611.79556.AE

A. Gressner, R. Weiskirchen, K. Breitkopf, and S. Dooley, Roles of TGF-beta in hepatic fibrosis, Frontiers in Bioscience, vol.7, issue.4, pp.793-807, 2002.
DOI : 10.2741/A812

K. Flanders, Smad3 as a mediator of the fibrotic response, International Journal of Experimental Pathology, vol.282, issue.2, pp.47-64, 2004.
DOI : 10.1111/j.0959-9673.2004.00377.x

K. Flanders, C. Sullivan, M. Fujii, A. Sowers, M. Anzano et al., Mice Lacking Smad3 Are Protected Against Cutaneous Injury Induced by Ionizing Radiation, The American Journal of Pathology, vol.160, issue.3, pp.1057-1068, 2002.
DOI : 10.1016/S0002-9440(10)64926-7

J. Zhao, W. Shi, Y. Wang, H. Chen, P. Bringas et al., Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice, American Journal of Physiology - Lung Cellular and Molecular Physiology, vol.282, issue.3, pp.585-593, 2002.
DOI : 10.1152/ajplung.00151.2001

P. Bonniaud, M. Kolb, T. Galt, J. Robertson, C. Robbins et al., Smad3 Null Mice Develop Airspace Enlargement and Are Resistant to TGF-??-Mediated Pulmonary Fibrosis, The Journal of Immunology, vol.173, issue.3, pp.2099-2108, 2004.
DOI : 10.4049/jimmunol.173.3.2099

A. Nakao, M. Fujii, R. Matsumura, K. Kumano, Y. Saito et al., Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice, Journal of Clinical Investigation, vol.104, issue.1, pp.5-11, 1999.
DOI : 10.1172/JCI6094

A. Roberts, F. Tian, S. Byfield, C. Stuelten, A. Ooshima et al., Smad3 is key to TGF-??-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis, Cytokine & Growth Factor Reviews, vol.17, issue.1-2, pp.19-27, 2006.
DOI : 10.1016/j.cytogfr.2005.09.008

C. Denton and D. Abraham, Transforming growth factor-?? and connective tissue growth factor: key cytokines in scleroderma pathogenesis, Current Opinion in Rheumatology, vol.13, issue.6, pp.505-511, 2001.
DOI : 10.1097/00002281-200111000-00010

A. Holmes, D. Abraham, S. Sa, X. Shiwen, C. Black et al., CTGF and SMADs, Maintenance of Scleroderma Phenotype Is Independent of SMAD Signaling, Journal of Biological Chemistry, vol.276, issue.14, pp.10594-10601, 2001.
DOI : 10.1074/jbc.M010149200

M. Vozenin-brotons, F. Milliat, J. Sabourin, A. De-gouville, A. Francois et al., Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression, International Journal of Radiation Oncology*Biology*Physics, vol.56, issue.2, pp.561-572, 2003.
DOI : 10.1016/S0360-3016(02)04601-1

G. Li, Q. Xie, Y. Shi, D. Li, M. Zhang et al., Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats, The Journal of Gene Medicine, vol.22, issue.7, pp.889-900, 2006.
DOI : 10.1002/jgm.894

P. Bonniaud, G. Martin, P. Margetts, K. Ask, J. Robertson et al., Connective Tissue Growth Factor Is Crucial to Inducing a Profibrotic Environment in ???Fibrosis-Resistant??? Balb/c Mouse Lungs, American Journal of Respiratory Cell and Molecular Biology, vol.31, issue.5, pp.510-516, 2004.
DOI : 10.1165/rcmb.2004-0158OC

M. Pines and A. Nagler, Halofuginone: A Novel Antifibrotic Therapy, General Pharmacology: The Vascular System, vol.30, issue.4, pp.445-450, 1998.
DOI : 10.1016/S0306-3623(97)00307-8

M. Pines, D. Snyder, S. Yarkoni, and A. Nagler, Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma, Biology of Blood and Marrow Transplantation, vol.9, issue.7, pp.417-425, 2003.
DOI : 10.1016/S1083-8791(03)00151-4

C. Denton and C. Black, Targeted therapy comes of age in scleroderma, Trends in Immunology, vol.26, issue.11, pp.596-602, 2005.
DOI : 10.1016/j.it.2005.09.002

Y. Gnainsky, Z. Kushnirsky, G. Bilu, Y. Hagai, O. Genina et al., Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-?? signaling, Cell and Tissue Research, vol.5, issue.1, pp.153-166, 2007.
DOI : 10.1007/s00441-006-0330-1

F. Verrecchia, M. Pessah, A. Atfi, and A. Mauviel, Tumor Necrosis Factor-?? Inhibits Transforming Growth Factor-?? /Smad Signaling in Human Dermal Fibroblasts via AP-1 Activation, Journal of Biological Chemistry, vol.275, issue.39, pp.30226-30231, 2000.
DOI : 10.1074/jbc.M005310200

URL : https://hal.archives-ouvertes.fr/inserm-00150046

F. Verrecchia, C. Tacheau, M. Schorpp-kistner, P. Angel, and A. Mauviel, Induction of the AP-1 members c-Jun and JunB by TGF-??/Smad suppresses early Smad-driven gene activation, Oncogene, vol.20, issue.18, pp.2205-2211, 2001.
DOI : 10.1038/sj.onc.1204347

F. Verrecchia, C. Tacheau, E. Wagner, and A. Mauviel, A Central Role for the JNK Pathway in Mediating the Antagonistic Activity of Pro-inflammatory Cytokines against Transforming Growth Factor-??-driven SMAD3/4-specific Gene Expression, Journal of Biological Chemistry, vol.278, issue.3, pp.1585-1593, 2003.
DOI : 10.1074/jbc.M206927200

F. Verrecchia, L. Vindevoghel, R. Lechleider, J. Uitto, A. Roberts et al., Smad3/AP-1 interactions control transcriptional responses to TGF-?? in a promoter-specific manner, Oncogene, vol.20, issue.26, pp.3332-3340, 2001.
DOI : 10.1038/sj.onc.1204448

F. Verrecchia, E. Wagner, and A. Mauviel, Distinct involvement of the Jun-N-terminal kinase and NF-??B pathways in the repression of the human COL1A2 gene by TNF-??, EMBO reports, vol.3, issue.11, pp.1069-1074, 2002.
DOI : 10.1093/embo-reports/kvf219

M. Schiller, F. Verrecchia, and A. Mauviel, Cyclic adenosine 3???,5???-monophosphate-elevating agents inhibit transforming growth factor-??-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism, Oncogene, vol.22, issue.55, pp.8881-8890, 2003.
DOI : 10.1038/sj.onc.1206871

URL : https://hal.archives-ouvertes.fr/inserm-00147460

V. Haydont, D. Mathe, C. Bourgier, J. Abdelali, J. Aigueperse et al., Induction of CTGF by TGF-??1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives, Radiotherapy and Oncology, vol.76, issue.2, pp.219-225, 2005.
DOI : 10.1016/j.radonc.2005.06.029